Who is Parexel owned by?

Who is Parexel owned by?

EQT IX Fund
Global clinical research organization PAREXEL International has agreed to be taken over from Pamplona Capital Management for $8.5 billion. Upon completion of the merger, Parexel will be owned by EQT IX Fund and the private equity business within Goldman Sachs Asset Management.

What is Parexel called now?

Contract research organization (CRO) Parexel announced on Jan. 11, 2021 that the company completed a strategic separation of its Informatics and Medical Imaging business, which has been established as a new company named Calyx.

How much is Parexel worth?

Biopharmaceutical company Parexel confirmed Tuesday morning it will be acquired by Pamplona Capital for $88.10 per share in cash, in a transaction valued at approximately $5 billion.

Is Parexel a pharmaceutical company?

Parexel International is an American provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process.

Is Parexel a good company?

Is Parexel a good company to work for? Parexel has an overall rating of 3.7 out of 5, based on over 2,673 reviews left anonymously by employees. 73% of employees would recommend working at Parexel to a friend and 63% have a positive outlook for the business.

Is Calyx owned by Parexel?

Calyx will remain privately held by the same ownership group that has owned and invested in Parexel since 2017.

Is Parexel private?

Parexel International is an American provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process….Parexel.

Has Parexel been sold?

By Jonathan Saltzman Globe Staff,Updated July 2, 2021, 1:46 p.m.

Is Parexel being sold?

Parexel is being sold for $8.5 billion by Pamplona Capital to Swedish private equity firm EQT and the private equity business of Goldman Sachs Asset Management.

What is the business of PAREXEL?

Parexel is in the business of improving the world’s health. As a leading global clinical research organization (CRO), we provide a suite of biopharmaceutical services that help clients across the globe transform scientific discoveries into new treatments.

How do I contact Parexel?

For general email inquiries, contact [email protected]. Alternatively, please complete the form below and we will contact you. Visit Parexel’s Preference Center to view and edit your communication preferences, topics of interest, and contact information.

What happened to Parexel?

The company was acquired by private equity firm Pamplona Capital Management for approximately $5.0 billion. The deal closed in September 2017. On July 2, 2021, Parexel announced a merger agreement under which it would be acquired by EQT IX fund and Goldman Sachs for $8.5 billion. EQT and Goldman Sachs completed the acquisition on November 15, 2021.

Is PAREXEL owned by EQT?

On July 2, 2021, Parexel announced a merger agreement under which it would be acquired by EQT IX fund and Goldman Sachs for $8.5 billion. EQT and Goldman Sachs completed the acquisition on November 15, 2021.

https://www.youtube.com/c/parexel